Abstract. A qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome is presented. The following lipids were identified in the urine of patients with the nephrotic syndrome: free cholesterol, cholesterol esters, triglycerides, free fatty acids, and phospholipids. Glass paper chromatography identified the cholesterol esters as palmitate, oleate, linoleate, and arachidonate, and identified the phospholipids as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine.
Introduction
Lipiduria is a commonly emphasized component of the nephrotic syndrome (1) . The term usually refers to the birefringent and/or anisotropic crys-*Submitted for publication 18 Orleans, La. tals found in the urinary sediment of patients with the nephrotic syndrome. These anisotropic bodies have the typical "Maltese cross" appearance when viewed with a polarizing microscope. Cholesterol esters have been identified by Zimmer et al. (2) as the major component of these elements. However, the qualitative and quantitative pattern of lipids excreted in the urine of patients with the nephrotic syndrome has not been elucidated. Our study was designed to clarify the nature of the lipids excreted in the urine of patients with the nephrotic syndrome as well as to gain insight into the mechanisms of urinary lipid excretion.
Methods 24-hr urine specimens were collected on 32 different occasions from five normal subjects, 13 patients with the nephrotic syndrome, four patients with hyperlipidemia Table I . In four patients with the nephrotic syndrome, samples of urine and blood were obtained on admission and after 4 wk of glucocorticoid therapy. Duplicate aliquots of 100 ml of each 24 hr urine specimen were dialyzed against 20 g of polyethylene glycol ("Carbowax," Union Carbide Corporation, New York, N. Y.) previously moistened and placed in dialysis tubing (3). The dialysis was carried out until the urine volume was reduced to 5 or 10 ml. This concentrated urine aliquot was extracted with a 2: 1 (v/v) chloroform-methanol ospholipids; Tg, triglycerides; Ccr, creatinine clearance; GN, mixture in the proportion of 20 volumes of solvent to 1 volume of urine. The extract was then filtered and subsequently washed with dilute sulfuric acid (0.03 N). The resulting purified chloroform layer was evaporated to dryness at temperatures ranging from 450 to 50°C and finally it was reconstituted with chloroform to a volume of 10 ml. Concentrated aliquots from the chloroform extract were analyzed in duplicate for total cholesterol, lipid phosphorus, triglycerides, and cholesterol esters.
Total cholesterol was estimated by the ferric chloride method of Zlatkis et al. (4) . Phospholipids were estimated in duplicate 1 ml aliquots to which 0.15 ml of concentrated sulfuric acid was added. This mixture was placed in a sand bath at 2800C for 20 min. After the addition of two drops of peroxide, the mixture was placed in the same sand bath for an additional 10 min. After cooling to room temperature, the lipid phosphorus was determined by the method of Fiske and Subbarow (5) . The qualitative determination of lipids and the quantification of triglycerides in the urine were performed using thin layer chromatography. Chromato-plates were prepared with silica gel G using a Stahl applicator (6) . Duplicate aliquots of 2.5 ml of the chloroform extract were evaporated to dryness and reconstituted with 0.5 ml of hexane. 20 Al were applied in duplicate to each chromatoplate and run using a solvent system of hexane-ethyl ether-acetic acid, 40: 10: 0.5 (v/v). Standards for free cholesterol, cholesterol esters, triglycerides, and free fatty acids were run simultaneously. After developing and drying, the chromatogram was exposed to iodine vapors which revealed the different spots. For the determination of triglycerides, the corresponding spots (identified by a triolein standard run simultaneously) were scraped off and dissolved in 3 ml of methanol. This eluate was evaporated to dryness and redissolved in 3 ml of a mixture of ethanol-ethyl ether, 3: 1 (v/v). Triglycerides were finally determined by the esterification of fatty acids with hydroxylamine using the method of Stern and Shapiro (7) . Cholesterol esters were separated by glass paper chromatography (8) . For this procedure duplicate 2-ml samples of the chloroform extract were evaporated to dryness and reconstituted with 0.5 ml of a mixture of isopropylic ether-ethanol, 1: 2 (v/v). Thereafter, duplicate 10-,.u samples of this extract were run using a solvent system of isooctane-isopropyl acetate, 50: 0.05 (v/v).-After development, the chromatogram was dried, sprayed with concentrated sulfuric acid, and placed in the oven at 1800C for 5 min.
Densitometries of the charred spots of standard and unknown samples were compared using a specially designed densitometer (9) . Urinary phospholipids were identified by glass paper chromatography using 20 A1. of a concentrated sample (5: 1). Samples were run in duplicate with a solvent system of isopropyl ether-methanol-basic solvent, 25: 3: 1 (v/v). The basic solvent was made up of ammonia and water, 2: 5 (v/v). The development of the chromatograms was similar to that described for the identification of cholesterol esters.
Blood samples were treated the same way as urine samples, with the exception of the concentrating procedure. Creatinine was determined by the method of Bonsnes and Taussky (10) . Total protein was quantitated by the micro-Kjeldahl method of Folin and Farmer (11) . The respective concentrations of albumin and globulin were determined by paper electrophoresis. Creatinine clearances were calculated with standard formulae (12) . i plasma In Fig. 3 , 24 hr urinary cholesterol excretion is dephroti plotted on the ordinate and "glomerular permenephrotw c ability" on the abscissa. Glomerular permeability 3hown 'in was calculated as described by Schreiner using n 13 pa-the data of albumin excretion, plasma albumin ) correla-levels, and creatinine clearance (15) . A good terol ex-correlation was observed between glomerular perexcretion meability and urinary cholesterol excretion. The o varied correlation coefficient was 0.81. If the regression d no cor-line, calculated by the method of least squares, was extrapolated to a glomerular permeability of 0, the calculated 24 hr urinary cholesterol excretion would be 2.5 mg, a figure similar to the mean of 2.7 mg of cholesterol excreted in the five normal subjects studied.
Effect of glucocorticoid therapy. (15) .
Discussion
Anisotropic lipid material has been observed in the urine sediment of patients with the nephrotic syndrome since the early 1900's. These glomerular anisotropic bodies have the well-known Maltese cross appearance when viewed with a polarizing microscope. Zimmer and his associates (2) pointed out that this anisotropic lipid material is apparently composed largely of cholesterol ester with a smaller proportion of free cholesterol. However, no attention has been given to the possibility of urinary excretion of lipids other than cholesterol esters and free cholesterol in nephrotic subjects. In our patients both thin layer chromatography and glass paper chromatography were employed, as previously described in Results, to show the presence of other lipids in the urine of patients with the nephrotic syndrome. The percentage distribution of urinary cholesterol esters was similar to the distribution of these same esters in plasma.
Several previous studies of the quantitative excretion of urinary cholesterol in various disease states have been made (13, 14, 16) . The range of normal in these studies was 0.15-4.2 mg/24 hr, a range very similar to the urinary excretion of cholesterol by our normal subjects (mean 2.7 mg). In our study, urinary lipid excretion was much greater in patients with the nephrotic syndrome than in patients with chronic renal disease and minimal proteinuria, or in patients with hyperlipidemia from other causes. Urinary lipid excretion varied widely among the 13 patients with the nephrotic syndrome studied, and no quantitative correlation with serum lipid levels was observed.
More than 30 yr ago Bing and Starup (17) reported a parallelism between protein and cholesterol excretion in a nephrotic patient studied over an 8 hr period whose cholesterol excretion was varied by cholesterol feeding. Neuman et al. (18) , in a study of 100 patients whose proteinuria was associated with a variety of diseases, showed a correlation between the degree of proteinuria and the number of fatty elements in the urine as determined by Sudan staining. Within our nephrotic group; four patients were studied before and after 4 wk of. glucocorticoid therapy.
In each patient, concomitant with a decrease in proteinuria there was a marked decrease in urinary cholesterol excretion, despite the fact that serum cholesterol levels did not -change appreciably. When urinary cholesterol excretion was plotted against protein excretion, a moderately good correlation was observed. If correction is allowed for plasma and albumin levels and glomerular filtration rate, the excretion of albumin in the final urine offers a rough estimate of glomerular permeability (15) . When the glomerular permeability, calculated as an albumin clearance corrected/100 ml of glomerular filtration rate, was plotted against urinary cholesterol excretion, a good correlation (r = 0.82) was obtained. All these observations support the idea that lipiduria in the nephrotic syndrome is related to protein loss and suggest that most of 'the urinary lipid enters the glomerular filtrate in the form of lipoprotein. Schrade et al. (19) demonstrated that lipoprotein is lost through damaged glomeruli in patients with proteinuria of any etiology. This lipoprotein could be partially reabsorbed by the tubule. The possibility that some of the lipid appearing in the urine is obtained from the blood through tubular secretion is unlikely but not entirely excluded. However, experiments with amphibians indicated that glomerular damage is necessary before cholesterol can enter the urine (20) ; and in dogs with dietary-induced hyperlipidemia no urinary cholesterol excretion could be detected until a renal lesion (presumably glomerular) had been produced with uranium nitrate (21) . In human beings the hypercholesterolemic state alone is not sufficient to produce abnormal amounts of urinary lipids. In only one of our patients with hyperlipidemia not due to the nephrotic syndrome was there an appreciable amount of urinary lipids. In this patient (D.S.) with biliary tract obstruction, the possibility that some of the lipid material in the urine could represent biliary acids was not completely excluded. It appears, therefore, that an increased glomerular permeability to lipoprotein is probably necessary before appreciable amounts of lipid appear in the urine.
